Endoscopy 2011; 43(6): 490-498
DOI: 10.1055/s-0030-1256357
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin

J.  G.  Albert1 , 2 , M.  Fechner2 , E.  Fiedler3 , W.  Voderholzer4 , H.  Lochs4 , U.  Trefzer5 , W.  Sterry5 , S.  Vay6 , W.  Stremmel6 , A.  Enk7 , W.  C.  Marsch3 , W.  E.  Fleig8 , P.  Helmbold7
  • 1Department of Medicine I, Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
  • 2First Department of Medicine, Martin Luther University, Halle (Saale), Germany
  • 3Department of Dermatology, Martin Luther University, Halle (Saale), Germany
  • 4Department of Medicine, Charité Medical University, Berlin, Germany
  • 5Department of Dermatology, Charité Medical University, Berlin, Germany
  • 6Department of Medicine, University of Heidelberg, Heidelberg, Germany
  • 7Department of Dermatology, University of Heidelberg, Heidelberg, Germany
  • 8University of Leipzig Hospital and Clinics, Leipzig, Germany
Further Information

Publication History

submitted 4 March 2010

accepted after revision 31 January 2011

Publication Date:
26 May 2011 (online)

Background and study aim: The aim of this study was to develop an algorithm to detect small-bowel metastasis (SBM) of melanoma by sequential laboratory parameters and pan-intestinal endoscopy (PIE) including video capsule endoscopy (VCE).

Patients and methods: A total of 390 melanoma patients (AJCC stage I/II/III/IV, 140/80/121/49) were screened for signs of intestinal blood loss (fecal occult blood test [FOBT] or overt bleeding) in an open, multicenter, prospective study, and those who were positive underwent PIE. Independent of the presence of intestinal bleeding, all stage IV patients were offered PIE. Follow-up was obtained in 357 patients (91.5 %) for a median of 16 months. We undertook to identify possible associations between SBM and clinical and laboratory data. Survival data were analyzed with regard to clinical and laboratory data and small-bowel findings.

Results: Intestinal blood loss was suspected in 49 of 390 patients (12.6 %), 38 of whom (77.6 %) agreed to undergo endoscopy. In 10 patients, SBM was detected by VCE (intention-to-diagnose, 20.4 %; AJCC III, n = 2; AJCC IV, n = 8). The SBM was resected in five patients. Total detection rates of SBM were 14 of 49 patients in stage IV (28.6 %, intention-to-diagnose), 2 of 121 in stage III (1.7 %), and 0 in stage I/II. In FOBT-positive patients, SBM detection rates were 72.7 %, 14.3 %, and 0 % in tumor stages IV, III, and I/II, respectively. Positive FOBT proved to be an independent negative prognostic factor for total survival in stage III and IV melanoma.

Conclusions: SBMs are frequent in advanced melanoma. In stage III patients, screening for intestinal blood loss by PIE may help to identify SBMs. In stage IV, indication for PIE should depend on the individual consequences of detecting SBM, but not on bleeding symptoms alone.

References

  • 1 Lasithiotakis K G, Leiter U, Gorkievicz R et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.  Cancer. 2006;  107 1331-1339
  • 2 McCaul K A, Fritschi L, Baade P, Coory M. The incidence of second primary invasive melanoma in Queensland, 1982 – 2003.  Cancer Causes Control. 2008;  19 451-458
  • 3 Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials.  Cancer. 2006;  107 (7 Suppl) 1645-1655
  • 4 Backman H, Davidsson L. Metastases of malignant melanoma in the stomach and small intestine.  Acta Med Scand. 1965;  178 329-335
  • 5 Poteshan N L. Metastatic tumor to the small bowel. Three cases simulating primary malignant tumors.  Am J Roentgenol Radium Ther Nucl Med. 1967;  99 122-126
  • 6 Macbeth W A, Gwynne J F, Jamieson M G. Metastatic melanoma in the small bowel.  Aust N Z J Surg. 1969;  38 309-315
  • 7 Richie R E, Reynolds V H, Sawyers J L. Tumor metastases to the small bowel from extra-abdominal sites.  South Med J. 1973;  66 1383-1387
  • 8 Byrd B F, Morton C EI. Malignant melanoma metastatic to the gastrointestinal tract from an occult primary tumor.  South Med J. 1978;  71 1306-1308
  • 9 Das Gupta T, Brasfield R. Metastatic melanoma of the gastrointestinal tract.  Arch Surg. 1964;  88 969-973
  • 10 Patel J K, Didolkar M S, Pickren J W, Moore R H. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases.  Am J Surg. 1978;  135 807-810
  • 11 Mosimann F, Fontolliet C, Genton A et al. Resection of metastases to the alimentary tract from malignant melanoma.  Int Surg. 1982;  67 257-260
  • 12 Lasithiotakis K G, Leiter U, Eigentler T et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001: which factors contributed?.  Cancer. 2007;  109 1174-1182
  • 13 Ollila D W, Essner R, Wanek L A, Morton D L. Surgical resection for melanoma metastatic to the gastrointestinal tract.  Arch Surg. 1996;  131 975-980
  • 14 Sharpless S M, Das Gupta T K. Surgery for metastatic melanoma.  Semin Surg Oncol. 1998;  14 311-318
  • 15 Panagiotou I, Brountzos E N, Bafaloukos D et al. Malignant melanoma metastatic to the gastrointestinal tract.  Melanoma Res. 2002;  12 169-173
  • 16 Essner R. Surgical treatment of malignant melanoma.  Surg Clin North Am. 2003;  83 109-156
  • 17 Ollila D W, Caudle A S. Surgical management of distant metastases.  Surg Oncol Clin N Am. 2006;  15 385-398
  • 18 Kadivar T F, Vanek V W, Krishnan E U. Primary malignant melanoma of the small bowel: a case study.  Am Surg. 1992;  58 418-422
  • 19 Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy.  Nature. 2000;  405 417
  • 20 Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine.  Lancet Oncol. 2009;  10 516-521
  • 21 Albert J G, Gimm O, Stock K et al. Small-bowel endoscopy is crucial for diagnosis of melanoma metastases to the small bowel: a case of metachronous small bowel metastases and review of the literature.  Melanoma Res. 2007;  17 335-338
  • 22 Reintgen D S, Thompson W, Garbutt J, Seigler H F. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract.  Surgery. 1984;  95 635-639
  • 23 Klaase J M, Kroon B B. Surgery for melanoma metastatic to the gastrointestinal tract.  Br J Surg. 1990;  77 60-61
  • 24 Branum G D, Seigler H F. Role of surgical intervention in the management of intestinal metastases from malignant melanoma.  Am J Surg. 1991;  162 428-431
  • 25 Ricaniadis N, Konstadoulakis M M, Walsh D, Karakousis C P. Gastrointestinal metastases from malignant melanoma.  Surg Oncol. 1995;  4 105-110
  • 26 Krige J E, Nel P N, Hudson D A. Surgical treatment of metastatic melanoma of the small bowel.  Am Surg. 1996;  62 658-663
  • 27 Agrawal S, Yao T J, Coit D G. Surgery for melanoma metastatic to the gastrointestinal tract.  Ann Surg Oncol. 1999;  6 336-344
  • 28 Gutman H, Hess K R, Kokotsakis J A et al. Surgery for abdominal metastases of cutaneous melanoma.  World J Surg. 2001;  25 750-758
  • 29 Sanki A, Scolyer R A, Thompson J F. Surgery for melanoma metastases of the gastrointestinal tract: indications and results.  Eur J Surg Oncol. 2009;  35 313-319
  • 30 Geboes K, De Jaeger E, Rutgeerts P, Vantrappen G. Symptomatic gastrointestinal metastases from malignant melanoma. A clinical study.  J Clin Gastroenterol. 1988;  10 64-70
  • 31 Neu B, Ell C, May A et al. Capsule endoscopy versus standard tests in influencing management of obscure digestive bleeding: results from a German multicenter trial.  Am J Gastroenterol. 2005;  100 1736-1742
  • 32 Triester S L, Leighton J A, Leontiadis G I et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding.  Am J Gastroenterol. 2005;  100 2407-2418
  • 33 Albert J G, Martiny F, Krummenerl A et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis.  Gut. 2005;  54 1721-1727
  • 34 Cobrin G M, Pittman R H, Lewis B S. Increased diagnostic yield of small bowel tumors with capsule endoscopy.  Cancer. 2006;  107 22-27
  • 35 Bailey A A, Debinski H S, Appleyard M N et al. Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience.  Am J Gastroenterol. 2006;  101 2237-2243
  • 36 Prakoso E, Selby W S. Capsule endoscopy in patients with malignant melanoma.  Am J Gastroenterol. 2007;  102 1204-1208
  • 37 Balch C M, Buzaid A C, Soong S J et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.  J Clin Oncol. 2001;  19 3635-3648
  • 38 Verdecchia A, Francisci S, Brenner H et al. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data.  Lancet Oncol. 2007;  8 784-796
  • 39 Ries L, Harkins D, Krapcho M et al. SEER Cancer Statistics Review, 1975–2004, National Cancer Institute. Bethesda. 2007 http://seer.cancer.gov/csr/1975_2004/ based on November 2006 SEER data submission, posted to the SEER web site 2007. Last accessed 26 November 2009
  • 40 Balch C M, Soong S J, Gershenwald J E et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.  J Clin Oncol. 2001;  19 3622-3634
  • 41 de la Monte S M, Moore G W, Hutchins G M. Patterned distribution of metastases from malignant melanoma in humans.  Cancer Res. 1983;  43 3427-3433
  • 42 Bender G N, Maglinte D D, McLarney J H et al. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance.  Am J Gastroenterol. 2001;  96 2392-2400
  • 43 Galmiche J P, Coron E, Sacher-Huvelin S. Recent developments in capsule endoscopy.  Gut. 2008;  57 695-703
  • 44 Rosenberg S A, Yang J C, Topalian S L et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.  JAMA. 1994;  271 907-913
  • 45 Middleton M, Hauschild A, Thomson D et al. Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-alpha2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.  Ann Oncol. 2007;  18 1691-1697
  • 46 Hill J H, Krementz E T, Hill H Z. Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).  Cancer. 1984;  53 1299-1305
  • 47 Elsayed A M, Albahra M, Nzeako U C, Sobin L H. Malignant melanomas in the small intestine: a study of 103 patients.  Am J Gastroenterol. 1996;  91 1001-1006
  • 48 Ollila D W. Complete metastasectomy in patients with stage IV metastatic melanoma.  Lancet Oncol. 2006;  7 919-924
  • 49 Richmond A. CCR9 homes metastatic melanoma cells to the small bowel.  Clin Cancer Res. 2008;  14 621-623
  • 50 Amersi F F, Terando A M, Goto Y et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.  Clin Cancer Res. 2008;  14 638-645

J. G. AlbertMD 

Department of Medicine I
Johann Wolfgang Goethe University Frankfurt

D- 60590 Frankfurt/Main
Germany

Fax: +49-69-63016448

Email: joerg.albert@kgu.de